Vietnam’s pharmaceutical industry is rapidly emerging as one of Southeast Asia’s most dynamic healthcare markets. Rising healthcare awareness, increasing income levels, an aging population, and expanding medical infrastructure are driving substantial demand for imported medicines and healthcare products. While domestic pharmaceutical manufacturing continues to develop, Vietnam still depends heavily on imported drugs, biologics, vaccines, and active pharmaceutical ingredients (APIs).

According to the latest vietnam trade data and vietnam shipment data, Vietnam pharmaceutical imports reached approximately USD 4.30 billion in 2025. Although this represented a slight decline compared to the previous year, the market continues to show strong long-term growth potential. Today, Vietnam ranks among the fastest-growing pharmaceutical economies in Asia, creating significant opportunities for global suppliers and pharmaceutical importers in Vietnam.

The country’s healthcare transformation is also changing the structure of pharmaceutical demand. Consumers increasingly prefer high-quality imported medicines, while hospitals and healthcare institutions continue sourcing advanced therapeutic products from global pharmaceutical manufacturers. As a result, pharmaceutical importers in Vietnam are playing an increasingly important role in ensuring stable medicine supply chains across the country.

Vietnam Pharmaceutical Market Overview

Vietnam’s pharmaceutical market has experienced consistent growth over the past decade. Industry analysts estimate that the market value reached nearly USD 7–8 billion in 2025 and is projected to exceed USD 14 billion by 2034. Growth is being fueled by both demographic and economic changes.

Several factors are contributing to the expansion of the pharmaceutical sector:

• Rapid urbanization
• Rising middle-class population
• Higher healthcare spending
• Expansion of universal healthcare coverage
• Increasing prevalence of chronic diseases such as diabetes and cardiovascular disorders

These structural trends are generating long-term demand for imported pharmaceutical products. Consequently, pharmaceutical importers in Vietnam are expanding their sourcing networks and strengthening partnerships with international suppliers.

Vietnam’s healthcare system is also modernizing rapidly. New hospitals, clinics, and specialty treatment centers are increasing the need for advanced medicines, biologics, and specialty therapies. Despite improvements in local production capabilities, imported pharmaceuticals continue to dominate high-value therapeutic segments.

Vietnam Pharmaceutical Import Data 2025

According to recent vietnam shipment data, pharmaceutical imports into Vietnam reached USD 4.30 billion in 2025. While imports declined slightly from the previous year, the overall market remains significantly larger than it was just a few years ago.

Import growth has been driven by rising healthcare consumption and greater access to modern medical treatment. Monthly import trends during 2025 also revealed strong fluctuations, suggesting seasonal demand, inventory adjustments, and supply chain optimization by pharmaceutical importers in Vietnam.

Vietnam imports a broad range of pharmaceutical products, including:

• Finished pharmaceutical products
• Active pharmaceutical ingredients (APIs)
• Vaccines and biologics
• Specialty and patented drugs
• Hospital medicines and injectables

Domestic pharmaceutical production primarily focuses on low-cost generics and common therapeutic categories. However, advanced therapies and high-value medicines are still largely imported from developed pharmaceutical markets.

Top Pharmaceutical Supplier Countries to Vietnam

Vietnam sources pharmaceutical products from multiple countries worldwide. The country’s import structure reflects strong demand for high-quality medicines, advanced research capabilities, and globally trusted pharmaceutical brands.

The leading supplier countries in 2025 included:

United States

The USA remained one of the largest pharmaceutical suppliers to Vietnam. American pharmaceutical products are highly regarded for innovation, biologics, vaccines, and specialty medicines.

France

France continued to play a major role in Vietnam’s pharmaceutical imports, supplying premium branded medicines and advanced healthcare products.

Germany

German pharmaceutical companies maintained strong market share through innovative drugs, medical technologies, and advanced therapeutic solutions.

India

India strengthened its position as a major supplier of affordable generic medicines and APIs. Indian exporters continue to benefit from growing demand among pharmaceutical importers in Vietnam seeking cost-effective healthcare products.

Italy and South Korea

Italy and South Korea also contributed significantly to Vietnam’s pharmaceutical market by supplying specialty drugs, injectables, and advanced healthcare solutions.

These import patterns highlight Vietnam’s preference for products sourced from countries with strong regulatory standards, advanced R&D capabilities, and trusted pharmaceutical manufacturing systems.

Role of Pharmaceutical Importers in Vietnam

The role of pharmaceutical importers in Vietnam has become increasingly important as healthcare demand continues to rise. These companies serve as critical links between global manufacturers and Vietnam’s hospitals, pharmacies, and healthcare providers.

Large distributors manage nationwide supply chains and maintain partnerships with multinational pharmaceutical firms. They also oversee logistics, regulatory approvals, customs clearance, and cold-chain management for temperature-sensitive products.

Leading pharmaceutical importers in Vietnam include:

• Zuellig Pharma Vietnam
• DKSH Vietnam
• Vimedimex
• Pharmacity JSC
• Sapharco
• Imexpharm Corporation
• Pymepharco
• DHG Pharmaceutical JSC

These companies collectively handle billions of dollars in pharmaceutical imports each year and maintain extensive distribution networks across Vietnam.

In addition to large distributors, specialized importers focus on specific therapeutic categories such as oncology drugs, vaccines, biologics, and rare disease treatments. This specialization is helping pharmaceutical importers in Vietnam address increasingly sophisticated healthcare demands.

Importance of the Vietnam Pharmaceutical Buyer Network

The expanding Vietnam pharmaceutical buyer network is creating major opportunities for exporters worldwide. Pharmaceutical companies seeking entry into Southeast Asia often view Vietnam as a strategic gateway market due to its rapid economic growth and rising healthcare consumption.

A typical Vietnam pharmaceutical buyer may include:

• Pharmaceutical distributors
• Hospital procurement departments
• Retail pharmacy chains
• Government healthcare agencies
• Specialty drug importers
• Multinational pharmaceutical companies

Understanding the purchasing behavior of a Vietnam pharmaceutical buyer is essential for exporters looking to establish long-term business relationships. Buyers increasingly prioritize quality assurance, regulatory compliance, competitive pricing, and reliable supply continuity.

As healthcare demand grows, the Vietnam pharmaceutical buyer landscape is becoming more sophisticated and data-driven. Importers now rely heavily on trade intelligence, shipment analysis, and sourcing diversification strategies.

Vietnam Pharmaceutical Importers Database and Market Intelligence

A reliable Vietnam pharmaceutical importers database has become an essential business tool for pharmaceutical exporters, manufacturers, and healthcare suppliers. Access to verified importer records allows companies to identify active buyers, analyze shipment patterns, and evaluate market opportunities.

A comprehensive Vietnam pharmaceutical importers database typically includes:

• Importer company names
• Shipment records
• Product categories
• Supplier countries
• HS codes
• Import volumes and values
• Licensing information

Businesses can use a Vietnam pharmaceutical importers database to generate leads, monitor competitor activity, and identify high-growth therapeutic categories.

The growing availability of vietnam trade data is also transforming strategic planning within the pharmaceutical sector. Import-export intelligence helps companies better understand sourcing trends, pricing movements, and evolving demand patterns.

Meanwhile, vietnam shipment data provides detailed insights into import volumes, supplier relationships, and product flow across Vietnam’s pharmaceutical supply chain.

Why Vietnam Still Relies on Pharmaceutical Imports

Despite progress in domestic manufacturing, Vietnam continues to rely heavily on imported pharmaceuticals for several important reasons.

Limited High-Tech Manufacturing

Most domestic pharmaceutical companies focus on generic medicine production. Advanced biologics, innovative therapies, and patented medicines still require international sourcing.

API Dependence

Vietnam remains dependent on imported APIs for pharmaceutical manufacturing. Local production capabilities for raw pharmaceutical materials remain limited.

Quality Perception

Imported medicines are often viewed as higher quality and more reliable by both healthcare professionals and consumers.

Regulatory Challenges

Although regulatory reforms have improved approval timelines, local innovation and advanced manufacturing still face operational and compliance barriers.

As a result, pharmaceutical importers in Vietnam continue to play a central role in meeting the country’s healthcare needs.

Regulatory Improvements and Market Modernization

Vietnam has made substantial progress in pharmaceutical regulation and healthcare governance in recent years. The government has accelerated drug approval timelines and improved alignment with international pharmaceutical standards.

Regulatory modernization has created several positive outcomes:

• Faster market entry for imported medicines
• Improved compliance procedures
• Greater transparency in approvals
• Increased investor confidence

These reforms are making Vietnam more attractive for global pharmaceutical exporters and strengthening the position of pharmaceutical importers in Vietnam.

At the same time, the government is encouraging local manufacturers to upgrade facilities to EU-GMP standards and expand domestic production capacity.

Opportunities for Global Exporters

Vietnam’s pharmaceutical market presents major opportunities for international suppliers and healthcare businesses.

High-demand therapeutic categories include:

• Oncology drugs
• Cardiovascular medicines
• Diabetes treatments
• Vaccines and biologics
• Specialty medicines
• Affordable generics

Exporters can improve market entry success by partnering with experienced pharmaceutical importers in Vietnam that already possess strong distribution capabilities and regulatory expertise.

Participation in government tenders and hospital procurement programs also offers significant growth potential for foreign pharmaceutical suppliers.

The increasing sophistication of the Vietnam pharmaceutical buyer network further supports long-term export expansion.

Challenges in Vietnam’s Pharmaceutical Import Market

While Vietnam offers strong growth potential, companies must also navigate several market challenges.

Competitive Pressure

Global pharmaceutical companies and Indian generic manufacturers maintain strong market presence in Vietnam.

Pricing Controls

Government pricing regulations and competitive tender systems can affect profit margins.

Distribution Complexity

Vietnam’s pharmaceutical distribution network remains fragmented, with thousands of wholesalers and retail pharmacies operating nationwide.

Regulatory Compliance

Documentation requirements and changing import policies require careful market monitoring.

Despite these challenges, demand fundamentals remain highly favorable for pharmaceutical importers in Vietnam and global suppliers.

Future Outlook for Vietnam’s Pharmaceutical Industry

Vietnam’s pharmaceutical sector is expected to maintain strong long-term growth momentum through 2030 and beyond. Rising healthcare demand, population aging, and expanding medical infrastructure will continue driving pharmaceutical consumption.

Industry forecasts suggest:

• Continued market growth above 7% CAGR
• Expanding demand for specialty medicines
• Greater investment in healthcare infrastructure
• Rising biologics and vaccine consumption
• Increased digitalization of pharmaceutical supply chains

Although local manufacturing will gradually expand, imports are expected to remain above USD 4 billion annually in the medium term.

This ensures continued opportunities for pharmaceutical importers in Vietnam, global manufacturers, and healthcare suppliers seeking access to Southeast Asia’s growing healthcare economy.

Conclusion

Vietnam’s pharmaceutical industry is entering a transformative growth phase driven by rising healthcare demand, expanding infrastructure, and evolving consumer expectations. Despite growing domestic production capabilities, the country continues to depend heavily on imported pharmaceuticals, particularly for advanced therapies, biologics, vaccines, and APIs.

For global exporters, Vietnam offers substantial long-term opportunities. Success in this market depends on understanding the needs of the Vietnam pharmaceutical buyer ecosystem, building strong partnerships with pharmaceutical importers in Vietnam, and leveraging accurate vietnam trade data and vietnam shipment data for informed decision-making.

Businesses that invest in reliable market intelligence, strategic distribution partnerships, and regulatory compliance will be well-positioned to capitalize on Vietnam’s rapidly growing pharmaceutical sector in the years ahead.